home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  

registry of biomedical companies

  April 25, 2018
promoting the transfer of scientific know-how between industry and academia
Registry of biomedical companies:

[1] [3] [4] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 577 active entries


6100, avenue Royalmount
Montreal, QC, H4P 2R2

Phone: 450-688-6068
Fax: 514-496-9021


REPLICor is a biopharmaceutical company developing a new antiviral drug that will revolutionize the treatment of patients with chronic hepatitis B and for patients with  hepatitis D. This antiviral drug is currently being tested in clinical trials in Asia and Moldova to demonstrate its safety and activity in human patients. It is expected that our drug will also find important applications in the treatment of patients infected with influenza, RSV and CMV.

Selected Categories:
Product Company   Service Company
- Research
- Research
- Research

Last update of this entry: September 06, 2016

home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.